Next, we verified the seven peptides with more PBMC samples of convalescent COVID-19 patients and showed that the seven peptides could induce CD4+ IFN-γ+ T-cell and/or CD8+ IFN-γ+ T-cell-positive response (Figure 1D). The gene discussed is CD4; the disease is COVID-19.